Discusses mechanisms of resistance to etoposidechemotherapy. Involvement of selection or induction mechanisms; Mutation rates for cellular resistance; Nature of the single-step selected surviving clones; Estimated mutation rates; Cross-resistance of stably resistant clones to doxorubicin; Selection of spontaneously arising mutants for stable resistance.